Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Saxenda® for Weight Loss in Obesity
Recruiting0 awards1 criteria
Lubbock, Texas
This trial tests Saxenda®, an injectable medication that helps with weight loss by reducing hunger and increasing feelings of fullness. The study targets individuals in a weight loss program to see how the medication affects their brain's response to food and their overall weight loss.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service